日期:
2020 年 — 2026 年
2020
2021
2022
2023
2024
2025
2026
影响因子:

Monitoring overall survival in pivotal trials in indolent cancers

监测惰性癌症关键试验中的总体生存期

Fleming, Thomas R; Hampson, Lisa V; Bharani-Dharan, Bharani; Bretz, Frank; Chakravartty, Arunava; Coroller, Thibaud; Koukouli, Evanthia; Wittes, Janet; Yateman, Nigel; Zuber, Emmanuel

End points in clinical trials in diffuse large B-cell lymphoma: time for more dialogue?

弥漫性大B细胞淋巴瘤临床试验的终点:是时候进行更多对话了吗?

Degtyarev, Evgeny; Bolaños, Natacha; Brody, Joshua D; Buchbinder, Aby; Buyse, Marc; Fuchs, Miriam; Halabi, Susan; Hemmings, Robert; Masood, Aisha; Newsome, Simon; Saxton, Claire; Warwick, Lorna; Yateman, Nigel A; Zuber, Emmanuel

Thyroid-stimulating antibody activity between different immunoglobulin G subclasses

不同免疫球蛋白G亚类之间的促甲状腺抗体活性

Weetman, A P; Yateman, M E; Ealey, P A; Black, C M; Reimer, C B; Williams, R C Jr; Shine, B; Marshall, N J